China Pharma submits plan of compliance to NYSE American

The company was directed to submit a plan of compliance by July 15, 2022

Enveda appoints Vanitha Sekar as Chief Business Officer

She joins Enveda from Gilead Sciences

China medical devices market to surpass $42 billion in 2022: GlobalData

Domestic devices are usually preferred over imported medical devices in the national or regional procurement.

AMPEL BioSolutions' predicts drug options with RNA analytics & machine learning

Pfizer to achieve net-zero standard by 2040

Pfizer aims to achieve net-zero targets ten years earlier than the expectations of the Net-Zero Standard

Akebia Therapeutics regaining rights to Vadadustat in the US, Europe and China

Companies finalize termination with an agreed-upon settlement fee of $55M to be paid to Akebia

Cosentyx receives expanded approvals in EU for use in childhood arthritic conditions

Safety in these pediatric populations was consistent with the known safety profile across approved adult and pediatric indications1,2

DTx Pharma appoints Peter Condon as Chief Business Officer

Condon joins DTx Pharma with more than 20 years of experience in business development, commercial planning, and operations.

MEI Pharma appoints Anne Frese as Chief People Officer

Most recently, she served as chief human resources officer at Vyripharm Enterprises.

Merck appoints Chirfi Guindo as CMO for Merck Human Health

Guindo will be responsible for leading the development and implementation of the company’s long-term strategy for the Human Health portfolio.